Section 3

What the past five years can and cannot show

The first mistaken conclusion is that hospital leadership turnover rose continuously through the pandemic and the period after it. It did not. The record is better read as a structural signal than as a single trend line.

Figure 1. What the recent turnover record can and cannot show. Sources: American College of Healthcare Executives (2023); Challenger, Gray and Christmas (2024, 2026a, 2026b).

Table 2. Complementary but not directly comparable

Section 3

Structural conditions surrounding the role

Four independent indicators describe a low-slack, high-complexity operating environment. They measure different constructs, over different periods, against different denominators, so they are shown separately rather than combined into a composite score.

Figure 2. Structural conditions surrounding the leadership role. Sources: American Hospital Association (2025, 2026); Kaufman Hall (2026). The succession figure is an improvement on earlier surveys, but it still means a substantial share of boards may begin succession only after a vacancy, and reactive searches are more likely to overvalue availability, familiarity, and social proof.

Derived indicator

Healthcare’s share of all CEO exits rose by almost half in a year

The report notes that hospital exits rose from 68 to 74 in the first half of 2026 while announced exits across all industries fell 26%. Stated that way, the sector signal is easy to dismiss as six additional events. Expressed as a share of the same source’s own total, it is considerably sharper.

What the share does and does not establish

Section 4

Why turnover happens: a multi-level explanation

Recent scholarship rejects a single-cause explanation. A 2025 systematic review of 30 empirical studies identified 46 unique predictors of hospital CEO turnover spanning organizational, environmental, personal, and prior-performance factors. A 2024 scoping review organized causes into organizational, performance, and personal domains, with organizational factors most common.

Leader traits alone therefore cannot explain exits. Board relations, role clarity, resources, performance expectations, market turbulence, institutional life cycle, and succession architecture must be modeled together with the executive’s experience and behavior.

Figure 3. Leadership turnover as a system outcome. Author-developed conceptual synthesis based on Hermes et al. (2025), Mathew et al. (2024a, 2024b), and succession research.

Section 5

Have we elevated the wrong leaders?

The critical question is not whether healthcare should stop promoting from within. It is whether internal advancement has become a default rather than an evidence-based decision.

Internal candidates can offer lower information asymmetry, known relationships, mission continuity, and faster access to informal networks. Those advantages are real. The risk begins when the advantages are treated as proof of readiness for a role whose work is materially different from the candidate’s prior scope.

Promotion decisions are especially vulnerable to halo effects. A leader may be respected, dependable, and politically skilled in a functional or local role. Observers then infer enterprise strategy, capital judgment, transformation capacity, or system-integration capability without direct evidence. The higher role can require different time horizons, stakeholder conflicts, and decision consequences. Performance at one level is relevant, but it is not sufficient evidence of performance at the next.

Figure 4. From selection proxies to decision-grade evidence. Tenure, familiarity, internal reputation, and prior title remain relevant signals, but each must be converted into verified evidence before it can support an appointment. Author-developed synthesis based on Barrick and Parks-Leduc (2019), Ford et al. (2018), Kristof-Brown et al. (2005), and Schepker et al. (2017).

The evidence prevents an outsider-first ideology too

A hospital-based study of 5,933 organizations found that succession led to short-term disruption in efficiency, and that outsider successors closed the efficiency gap more rapidly than insiders. A cross-industry meta-analysis of 13,578 successions nevertheless found no universal long-term benefit from succession, and identified conditions under which insiders performed better with less strategic change. During the 2020 shock, insider CEOs outperformed outsiders in a cross-industry sample. Candidate origin is a contingency variable, not a quality score.

Five questions that convert experience into evidence

A board should ask these of every finalist, internal and external alike.

Counterarguments that must be preserved

Section 5

Decomposing culture before selection

The thesis does not deny the value of culture. It rejects culture as an undifferentiated construct. Meta-analytic research shows that person-organization fit is related to attitudes and retention, so it should not be dismissed. Task-performance relationships, however, can be contaminated by interviewer similarity, informal criteria, and unstructured intuition.

Figure 5. Decomposing culture before selection. Ethical and mission obligations are noncompensatory selection gates. Local language, routines, informal networks, decision customs, and operating cadence require evidence of learning and stewardship. Author-developed synthesis based on Barrick and Parks-Leduc (2019), Kristof-Brown et al. (2005), and Tholen (2024).

Section 5, Table 3

Condition-first candidate-origin matrix

Candidate origin is a contingent consideration, not an independent quality score. Boards should replace internal-first and outsider-first habits with condition-first selection: define the organization’s strategic condition, then decide what evidence that condition requires.

Table 3, as published

Source: Table 3 in the report. Candidate origin is a contingent consideration, not an independent quality score.

Section 6

Nine testable hypotheses

Each hypothesis is stated prospectively with a mechanism, an empirical design, and a competing prediction, so the argument can be disproven or bounded. Environmental conditions shape the timing and concentration of turnover; selection mechanisms influence person-role-condition match; governance affects whether accountability is coherent; and the KPLS intervention is the unvalidated proposition to be tested.

Figure 6. Nine-hypothesis research architecture. The architecture prevents the hypotheses from being read as nine unrelated claims. Evidence badges reproduce the current evidence-status judgments in Table 4; H9 remains unvalidated.

Section 7

Knowledge-Based Portable Leadership Selection Model

KPLS is an author-developed decision framework. It is not a validated psychometric instrument and should initially be used as a structured governance protocol, not as a claim of precise prediction. Its purpose is to shift the unit of analysis from candidate familiarity to evidence of capability aligned with the organization’s strategic condition.

Figure 7. Knowledge-Based Portable Leadership Selection Model. Weights are illustrative and unvalidated; values and ethical integrity are noncompensatory gates.

Table 5. KPLS Stage 3 dimensions

Total weight equals 100%. Candidate origin and cultural familiarity are recorded but not scored.

Why origin and familiarity carry no weight

An internal candidate may earn a high portable-performance score through broad rotations, cross-market assignments, acquired-entity integration, enterprise projects, and verified outcomes. An external candidate may earn a low score if the record shows mobility without mastery, if outcomes are attributable to favorable conditions, or if the candidate cannot translate prior experience to the local clinical environment.

Cultural familiarity is replaced by two more precise judgments. Values alignment is assessed at Stage 1 as a threshold. Cultural learning and stewardship are assessed through behavior: how the candidate entered prior organizations, listened without becoming passive, identified protected values, built legitimate trust, and changed harmful routines.

The illustrative weights should be locally stress-tested. A distressed rural hospital, an academic medical center, a payer-provider enterprise, and a multistate ambulatory platform should not use identical subcriteria. The fixed principle is that weights follow the strategic condition and are approved before candidate interviews. Altering weights after meeting a favored candidate defeats the purpose of structure, which is why the tool above flags exactly that sequence.

Section 8

Will turnover accelerate through 2029?

The base-case forecast is selective acceleration. The word selective is essential. National turnover may not increase every year, and some systems deliberately retain incumbents during periods of uncertainty. The near future is better understood as divergence across organizational risk profiles than as an industry-wide wave of equal intensity.

The highest-risk systems combine several conditions at once: thin or deteriorating margins; an executive nearing retirement or already serving beyond an intended horizon; a major transformation portfolio; board disagreement or multiple governance principals; weak succession depth; repeated interim appointments; acquisition or role redesign; and visible workforce or medical-staff strain. No single variable should be interpreted as destiny. Their interaction is the concern.

Figure 8. Selective-acceleration risk architecture through 2029. The forecast is a concentration problem: these conditions become most consequential when they interact. Author-developed directional framework. Risk tiers are not validated probabilities.

Table 6. Directional turnover-risk tiers

Leading indicators, not exit announcements

A credible forecast should be updated quarterly and evaluated annually. The leading indicators include CEO tenure and retirement exposure, interim appointments, board-chair turnover, formal succession coverage, executive-team vacancy rate, transformation portfolio load, days cash on hand, operating margin, clinician engagement, manager turnover, medical-staff conflict, and changes to the executive’s role or authority. These can reveal instability before an exit is announced.

Section 9

Board and search committee action agenda

The mandate is defined before candidates are reviewed, values gates precede scoring, performance evidence is verified under a single rubric, and the governance contract is written before the offer. Onboarding and recalibration then continue the validation after appointment.

Figure 9. Condition-first board selection workflow. Author-developed governance protocol integrating the KPLS stages with the board action agenda.

Section 9

Onboarding as selection-risk control

Onboarding should be treated as a sequence of governance tests rather than a ceremonial orientation period. Each checkpoint produces board-visible evidence that the mandate, authority, diagnosis, resources, and organizational capability remain aligned.

Figure 10. First-year onboarding and governance timeline. Author-developed framework summarizing the detailed cadence in Table 7.

Table 7. Illustrative first-year onboarding and governance cadence

Illustrative cadence. Local boards should set their own intervals and named owners.

Section 10

Research agenda

The proposed hypotheses require a multi-source longitudinal research program. Public announcement data should be linked with hospital characteristics, executive biographies, board composition, financial performance, workforce indicators, quality measures, merger activity, and succession practices. Departure reasons must be coded independently rather than collapsed into a single turnover variable.

The highest-value study would follow healthcare executive appointments prospectively from the beginning of the search. Researchers would obtain the role specification, strategic condition, candidate pool, structured interview scores, evidence-verification records, board-selection rationale, governance contract, and onboarding plan. Outcomes would be measured at 6, 12, 24, and 36 months. Such a design would reduce retrospective storytelling and allow direct testing of selection-process fidelity.

Figure 11. Prospective multilevel design for testing the proposed model. Author-developed research design derived from the minimum requirements in Table 8.

Construct validation is the precondition for everything else

Portable leadership performance requires validation before it can be treated as a measure rather than a heuristic. Content validity should be established with boards, healthcare executives, clinicians, workforce leaders, patients, and search professionals. Interrater reliability should be tested using standardized candidate dossiers. Predictive validity should be evaluated against a balanced outcome set rather than margin alone. Discriminant validity must show that the construct adds information beyond tenure, prior title, education, network prestige, and subjective fit.

Table 8. Minimum design requirements

Finally, future research should distinguish leader effects from leadership-system effects. A CEO may perform differently depending on board quality, executive-team complementarity, managerial capacity, and capital availability. Multilevel designs should model the executive within the team, board, organization, market, and regulatory environment.

Section 11

Limitations

These limitations do not invalidate the argument. They set the level of confidence at which each part of it can be held.

Section 12

Conclusion

Healthcare leadership turnover is not adequately explained by fatigue, retirement, or a difficult labor market. It is produced by an interacting system of environmental turbulence, organizational condition, governance quality, selection criteria, leader capability, and succession maturity.

Over the last five years the visible pattern moved from pandemic-era suppression to a post-crisis rebound and then to persistent, uneven activity. Early 2026 data suggest hospitals may remain exposed even as CEO turnover cools elsewhere, but the available measures do not justify a simple claim of uninterrupted acceleration.

The sector should reconsider the assumption that internal advancement and cultural fit are the safest default. Internal leaders can be exceptional, and their organization-specific knowledge can be decisive. The problem is using familiarity as evidence that has not been earned. External leaders can bring pattern recognition and a broader repertoire, but external status is equally incapable of proving fit or effectiveness.

The reform, stated as a sequence

Culture should remain central as values and stewardship, not as a vague preference for similarity. That is the narrower and more defensible version of the cultural claim, and it is the one the evidence supports.

Section 2

Method and evidence boundaries

This report is a critical integrative evidence synthesis, not a PRISMA systematic review and not a causal estimate of the national turnover rate. It combines recent peer-reviewed reviews of healthcare CEO turnover, hospital-specific succession studies, cross-industry meta-analytic evidence, organizational fit research, learning agility research, healthcare management studies, and current industry surveillance. The primary analytic window is 2020 through the first half of 2026.

Evidence was weighted by design and proximity to the question. Recent systematic reviews, meta-analyses, and large hospital samples received the greatest interpretive weight. Prospective healthcare cohorts, validated measurement studies, and multi-sample studies were treated as moderate evidence. Qualitative studies were used to illuminate mechanisms, not prevalence. Industry reports were used for current counts, financial context, and governance surveillance, but not as substitutes for peer-reviewed causal evidence.

Table 1. Evidence-strength convention

Three boundaries that constrain every claim

Quality control

Verification ledger

Every quantitative claim in the report was recomputed from the published values. The ledger is shown rather than silently corrected, so a reader can see which figures reproduce exactly and where a rounding judgment was made.

Relative changes are descriptive calculations from published endpoints and do not incorporate survey-estimation uncertainty.

References

The reference list prioritizes recent systematic reviews and meta-analyses, hospital-specific succession studies, validated measurement work, and current industry surveillance.